Acetyldigoxin

From Self-sufficiency
Revision as of 20:31, 18 August 2010 by Edgar181 (Talk) (Removed Category:Acetates; Adding category Category:Acetate esters (using HotCat))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Acetyldigoxin
File:Acetyldigoxin.png
Systematic (IUPAC) name
[6-[6-[ [6-[ [12,14-dihydroxy-10,13-dimethyl-17-

(5-oxo-2H-furan-3-yl) -1,2,3,4,5,6,7,8,9,11,12,15,16,17 -tetradecahydrocyclopenta[a]phenanthren- 3-yl]oxy]-4-hydroxyoxan-2-yl]methoxy]- 4-hydroxy-2-methyloxan-3-yl]oxy-3-

hydroxy-2-methyloxan-4-yl] acetate
Clinical data
Routes of
administration
Oral
Pharmacokinetic data
Bioavailability 90%(Oral)
Protein binding 20-30%
Biological half-life 40h
Identifiers
CAS Number 5511-98-8
ATC code C01AA02 (WHO)
PubChem CID 91545
Chemical data
Formula C43H66O15
Molar mass 822.975 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Acetyldigoxin is a cardiac glycoside. It is an acetyl derivative of digoxin. Its positive cardioinotropic effect starts after 3-4h and maximizes after 6-8h. It is prescribed for congestive chronic cardiac failure class II, III and IV from different reasons, tachysystolic form of fibrillation and proximal